Morgan Stanley’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-154,118
| Closed | -$2.78M | – | 8384 |
|
|
2025
Q1 | $2.78M | Sell |
154,118
-32,699
| -18% | -$581K | ﹤0.01% | 4397 |
|
|
2024
Q4 | $3.26M | Sell |
186,817
-6,104
| -3% | -$82.6K | ﹤0.01% | 4332 |
|
|
2024
Q3 | $2.22M | Sell |
192,921
-168,246
| -47% | -$1.93M | ﹤0.01% | 4572 |
|
|
2024
Q2 | $4.09M | Sell |
361,167
-313,373
| -46% | -$4.17M | ﹤0.01% | 4045 |
|
|
2024
Q1 | $9.66M | Sell |
674,540
-6,923,290
| -91% | -$98.1M | ﹤0.01% | 3374 |
|
|
2023
Q4 | $104M | Buy |
7,597,830
+4,096,307
| +117% | +$43.1M | ﹤0.01% | 1679 |
|
|
2023
Q3 | $28.5M | Sell |
3,501,523
-9,856
| -0.3% | -$80.6K | ﹤0.01% | 2089 |
|
|
2023
Q2 | $26.6M | Buy |
3,511,379
+21,080
| +0.6% | +$161K | ﹤0.01% | 2175 |
|
|
2023
Q1 | $27.9M | Buy |
3,490,299
+33,370
| +1% | +$343K | ﹤0.01% | 2082 |
|
|
2022
Q4 | $39.3M | Buy |
3,456,929
+3,380,554
| +4,426% | +$36.9M | ﹤0.01% | 1706 |
|
|
2022
Q3 | $666K | Sell |
76,375
-24,922
| -25% | -$259K | ﹤0.01% | 5115 |
|
|
2022
Q2 | $1.01M | Buy |
101,297
+34,081
| +51% | +$343K | ﹤0.01% | 5009 |
|
|
2022
Q1 | $677K | Buy |
67,216
+885
| +1% | +$9.41K | ﹤0.01% | 5221 |
|
|
2021
Q4 | $841K | Buy |
66,331
+38,499
| +138% | +$501K | ﹤0.01% | 5197 |
|
|
2021
Q3 | $348K | Buy |
27,832
+13,777
| +98% | +$187K | ﹤0.01% | 5702 |
|
|
2021
Q2 | $212K | Buy |
14,055
+10,780
| +329% | +$162K | ﹤0.01% | 5985 |
|
|
2021
Q1 | $45K | Sell |
3,275
-68,896
| -95% | -$1.07M | ﹤0.01% | 6394 |
|
|
2020
Q4 | $1.31M | Buy |
72,171
+12,145
| +20% | +$187K | ﹤0.01% | 4492 |
|
|
2020
Q3 | $762K | Buy |
+60,026
| New | +$753K | ﹤0.01% | 4400 |
|
Morgan Stanley's PTVE Position: Q2 2025 in Review
Morgan Stanley sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2025, closing a stake of 154,118 shares — an estimated $2.78M sold.
Morgan Stanley first reported a position in PTVE in Q3 2020 and held it in 19 quarters. The position peaked at $104M in Q4 2023. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.
- Morgan Stanley reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2025 after selling out during the quarter.
- Morgan Stanley sold 154,118 Pactiv Evergreen Inc. Common stock shares in Q2 2025, an estimated $2.78M.
- Morgan Stanley first reported a position in Pactiv Evergreen Inc. Common stock in Q3 2020 and held it in 19 quarters.
- Morgan Stanley's Pactiv Evergreen Inc. Common stock position peaked at $104M in Q4 2023.
- 0 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2025.
Based on Morgan Stanley's 13F filing for Q2 2025, filed 15 Aug 2025.